Mumbai, Jan 20 (IANS) The Indian stock market extended its losses on Tuesday, ending the session sharply lower as investors remained cautious amid rising global tensions and continued to react to company-specific developments during the ongoing Q3 earnings season.Benchmark indices witnessed heavy selling throughout the day. The Sensex closed at 82,180.47, down 1,065.71 points or 1.28 per cent.Meanwhile, the Nifty settled at 25,232.5, slipping 353 points or 1.38 per cent by the end of the session…
Latest Sun Pharma News & Updates
Mumbai, Jan 7 (IANS) Indian equity markets ended lower for the third consecutive session on Wednesday as ongoing geopolitical tensions kept investors on edge and selling pressure in automobile and oil marketing company stocks weighed on overall sentiment.At the close of trade, the Sensex slipped 102.20 points, or 0.12 per cent, to settle at 84,961.14. The Nifty also closed in the red, falling 37.95 points, or 0.14 per cent, to end at 26,140.75.“A sustained move above 26,300 would be required t…
Mumbai, Dec 31 (IANS) Indian equity markets ended the final trading session of the calendar year on a strong note, supported by broad-based buying across most sectors, even as information technology stocks remained under pressure.At the close of trade, the Sensex settled at 85,220.6, gaining 545.52 points or 0.64 per cent.The Nifty also finished higher at 26,129.6, up 190.75 points or 0.74 per cent. “Holding above the 26,000 mark remains crucial to sustain the ongoing uptrend and keep the poss…
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi’s clarion call, obesity became the focus of healthcare in India in 2025.The anti-obesity drive, especially the generic drugs, will continue to remain a key focus in 2026.Traditionally, Body Mass Index (BMI) was used to define obesity, but after 15 long years, India revamped its obesity guidelines in 2025 by lowering the thresh…
New Delhi, Dec 25 (IANS) Sun Pharma’s US arm, Taro Pharmaceutical Industries, has recalled more than 17,000 units of antifungal over manufacturing issues, the US Food and Drug Administration (USFDA) has said.The Ciclopirox Shampoo — an antifungal medication that treats seborrheic dermatitis (a condition that causes dry, flaky, and itchy skin) — is being recalled due to “failed impurity/degradation specifications”, the USFDA said, in its latest Enforcement Report.The Class II nationwide r…
Mumbai, Dec 24 (IANS) Indian stock market benchmarks Sensex and Nifty ended slightly lower on Wednesday as selling pressure in oil and gas, pharmaceutical and IT stocks weighed on the indices. Trading activity also remained dull as investors stayed cautious ahead of the Christmas holiday on Thursday.The Sensex closed at 85,408.70, slipping 116.14 points or 0.14 per cent. Similarly, the Nifty ended at 26,142.10, down 35.05 points or 0.13 per cent from the previous close.“The index gravitated to…